Benjamin Mina M, Sorkness Christine A
Divisions of Cardiovascular Medicine (Benjamin) and Allergy, Pulmonary, and Critical Care Medicine (Sorkness), Department of Medicine, University of Wisconsin Hospital, Madison, Wisconsin.
Proc (Bayl Univ Med Cent). 2017 Apr;30(2):157-160. doi: 10.1080/08998280.2017.11929566.
More than 4.5 million people worldwide live with an implanted pacemaker, including >3 million in the USA alone. Also, >0.8 million people in the USA have an implantable cardioverter defibrillator (ICD). Knowing the principles of managing these devices towards the end of life is important, as the interruption of their function may have serious consequences. This article provides health care providers who are not specialized in cardiac electrophysiology with an introduction to the general principles of management of pacemakers or ICD devices towards the end of life, with a suggested algorithm for approaching this process. Also discussed are pertinent ethical and practical considerations in deciding on and implementing a management strategy for these devices during terminal illnesses.
全球有超过450万人植入了起搏器，仅在美国就有超过300万人。此外，美国有超过80万人植入了植入式心脏复律除颤器（ICD）。了解在生命终末期管理这些设备的原则很重要，因为其功能中断可能会产生严重后果。本文为非心脏电生理学专业的医疗保健提供者介绍了起搏器或ICD设备在生命终末期管理的一般原则，并给出了处理这一过程的建议算法。还讨论了在终末期疾病期间决定并实施这些设备管理策略时相关的伦理和实际考虑因素。
